0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Psychopharmacology

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Research Letter  | 
Falls and Fractures With Atypical Antipsychotic Medication Use:  A Population-Based Cohort Study
Lisa-Ann Fraser, MD, MSc; Kuan Liu, MMath; Kyla L. Naylor, MES; et al.
JAMA Pediatrics
Original Investigation  | 
Injury Prevention by Medication Among Children With Attention-Deficit/Hyperactivity Disorder:  A Case-Only Study
Rafael Mikolajczyk, MD, PhD; Johannes Horn, Dipl Biomath; Niklas Schmedt, MA; et al.
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD